Research Findings

A new study finds that newborn babies experience antidepressant withdrawal after birth if their mothers take SSRIs when pregnant.

Leading ADHD researchers outline four mistakes that turned ADHD from a description of behavior into a medical disease.

Risk of depression increased when children were taking methylphenidate for ADHD, but once they stopped taking the drug, depression risk dropped to normal levels.

When comparing kids with the same symptoms who were either diagnosed with ADHD or not, those who received the diagnosis had worse outcomes.

A new study in rats found that those exposed to antidepressants in utero had an impaired ability to nurture their own children in later life.

Also, male mice born to mothers with an immune response exhibited “autistic-like” behaviors, scientists report.

According to researchers, children are being increasingly prescribed multiple different psychiatric medications.

“Efforts to improve learning in children with ADHD should focus on obtaining effective academic instruction rather than stimulant medication.”

Researchers discuss the evidence that antipsychotic medications may cause brain atrophy in children, whose brains are still developing.

Throughout the past two decades, studies have warned of increased suicide rates in those taking antidepressants, especially in children and adolescents. Researchers also documented...

Babies born to mothers taking antidepressants during pregnancy were more than six times as likely to have neonatal withdrawal syndrome—including breathing problems, irritability/agitation, tremors, feeding problems, and seizures—than those born to mothers taking other types of drugs.

Bias and financial conflicts in antidepressant trials “contribute to systematic underestimation of risk in the published literature.”

Mark Horowitz and David Taylor provide advice on how to tell the difference between antidepressant withdrawal and depression relapse.

A study conducted on college-aged students finds strong correlations between biomedical characterizations of mental illness, pharmaceutical treatment, and social stigma.

Noted antidepressant researcher, Michael Hengartner, summarizes the latest research on the use of antidepressants in children and adolescents.

A new study explores feelings of belongingness as a protective factor for childhood trauma and adult mental health outcomes.

Young women’s narratives indicate ways antidepressants have shaped their sense of self.

Neuroscience researchers find no differences in brain connectivity between children with diagnoses of autism, ADHD, and those with no diagnoses.

Medical researchers present evidence that ADHD is overdiagnosed in children and teens, which can lead to significant harm.

Withholding antipsychotics may be beneficial for memory, the researchers write.

A new article reviews studies in the field of nutritional psychiatry and how nutrition can prevent and treat mental health issues.

Researchers have found further evidence that the anticholinergic effect of psychiatric drugs can lead to cognitive impairments.

Researchers at Johns Hopkins test paroxetine on developing brain cells and discover numerous neurotoxic effects.

Yale study finds that training parents how to react to child behaviors is as effective at reducing anxiety as providing therapy to the child.

A new study suggests the way that marginalized youth view the mental health treatment they have received plays a role in the continuation of their care once they reach adulthood.